• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[刺激胰岛素释放的药物。它们在改善2型糖尿病血糖、安全性和生活质量方面的应用重要性]

[Drugs stimulating insulin release. Importance of their use for improving glycemia, safety and quality of life in diabetes mellitus type 2].

作者信息

Sieradzki J

机构信息

Katedra i Klinika Chorób Metabolicznych Uniwersytetu Jagiellońskiego w Krakowie.

出版信息

Przegl Lek. 2000;57(1):5-8.

PMID:10907360
Abstract

Etiopathogenesis of diabetes mellitus is bipolar. On one hand there occurs impairment in beta-cell function caused by genetic factors or abnormal development during fetal period. On the other hand defects of peripheral insulin action are also of significant importance. The bipolarity is also expressed by changing relationship between genetic and environmental factors. Insulin release is connected with closing ATP-dependent kalium channel, a structure closely connected with sulfonylurea receptors. Several receptors may be distinguished: SUR1 in Langerhans isles and SUR2 in heart (SUR2A) and vessel smoot muscles (SUR2B). In the treatment of insulin release disorders sulfonylureas are still of significant importance though repaglinid and phenyloalanine derivates also have some clinical importance. Within sulfonylurea derivates there have been developed some preparations of slow drug release (Glibenese GITS, Diaprel MR). One daily dose of Glibenese GITS and lower tendency to hypoglycaemia favour acceptation of the therapy by the patients what is also important for their quality of life. Quality of life is now regarded as important as obtaining good indices of diabetes control.

摘要

糖尿病的病因发病机制具有双相性。一方面,由于遗传因素或胎儿期发育异常导致β细胞功能受损。另一方面,外周胰岛素作用缺陷也具有重要意义。遗传因素与环境因素之间关系的变化也体现了这种双相性。胰岛素释放与关闭ATP依赖性钾通道有关,该结构与磺脲类受体紧密相连。可区分几种受体:胰岛中的SUR1以及心脏中的SUR2(SUR2A)和血管平滑肌中的SUR2B。在胰岛素释放障碍的治疗中,磺脲类药物仍然具有重要意义,尽管瑞格列奈和苯丙氨酸衍生物也具有一定临床意义。在磺脲类衍生物中,已开发出一些缓释制剂(格列本脲控释片、达美康缓释片)。格列本脲控释片每日一次给药且低血糖倾向较低,这有利于患者接受治疗,这对他们的生活质量也很重要。生活质量现在被认为与获得良好的糖尿病控制指标同样重要。

相似文献

1
[Drugs stimulating insulin release. Importance of their use for improving glycemia, safety and quality of life in diabetes mellitus type 2].[刺激胰岛素释放的药物。它们在改善2型糖尿病血糖、安全性和生活质量方面的应用重要性]
Przegl Lek. 2000;57(1):5-8.
2
[Molecular basis of oral hypoglycemic sulfonylurea action].[口服降糖磺脲类药物作用的分子基础]
Pol Merkur Lekarski. 2003 Nov;15(89):445-8.
3
[The role of sulphonylurea derivatives in treatment of diabetes type 2. The role of glimepiride].[磺酰脲类衍生物在2型糖尿病治疗中的作用。格列美脲的作用]
Przegl Lek. 2000;57 Suppl 4:13-8.
4
Treating diabetes today: a matter of selectivity of sulphonylureas.今日糖尿病治疗:磺酰脲类药物的选择性问题。
Diabetes Obes Metab. 2012 Jan;14 Suppl 1:9-13. doi: 10.1111/j.1463-1326.2011.01507.x.
5
Variations in tissue selectivity amongst insulin secretagogues: a systematic review.胰岛素促分泌剂在组织选择性方面的差异:系统评价。
Diabetes Obes Metab. 2012 Feb;14(2):130-8. doi: 10.1111/j.1463-1326.2011.01496.x. Epub 2011 Nov 3.
6
[Sulfonylurea drugs for type 2 diabetes].[用于2型糖尿病的磺脲类药物]
Nihon Rinsho. 2002 Sep;60 Suppl 9:339-45.
7
[Sulfonylurea receptors and their interaction with glimepiride].[磺脲类受体及其与格列美脲的相互作用]
Lik Sprava. 2003(2):35-9.
8
ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.ATP敏感性钾通道——新生儿糖尿病及其他情况
N Engl J Med. 2006 Aug 3;355(5):507-10. doi: 10.1056/NEJMe068142.
9
Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study.磺脲类受体1基因变异性对非胰岛素依赖型糖尿病患病率及治疗的影响:一项人群研究
Am J Med Genet. 2001 Jun 1;101(1):4-8. doi: 10.1002/ajmg.1297.
10
Sulfonylurea receptor gene 16-3 polymorphism - association with sulfonylurea or insulin treatment in type 2 diabetic subjects.磺脲类受体基因16-3多态性——与2型糖尿病患者磺脲类或胰岛素治疗的相关性
Med Sci Monit. 2002 Jul;8(7):CR512-5.